Skip to main navigation Skip to search Skip to main content

On the effectiveness of proton boron fusion therapy (PBFT) at cellular level

Mehrdad Shahmohammadi Beni, M. Rafiqul Islam, Kyeong Min Kim, Dragana Krstic, Dragoslav Nikezic, Kwan Ngok Yu*, Hiroshi Watabe*

*Corresponding author for this work

Research output: Journal Publications and ReviewsRGC 21 - Publication in refereed journalpeer-review

46 Downloads (CityUHK Scholars)

Abstract

The present work introduced a framework to investigate the effectiveness of proton boron fusion therapy (PBFT) at the cellular level. The framework consisted of a cell array generator program coupled with PHITS Monte Carlo package with a dedicated terminal-based code editor that was developed in this work. The framework enabled users to model large cell arrays with normal, all boron, and random boron filled cytoplasm, to investigate the underlying mechanism of PBFT. It was found that alpha particles and neutrons could be produced in absence of boron mainly because of nuclear reaction induced by proton interaction with 16O, 12C and 14N nuclei. The effectiveness of PBFT is highly dependent on the incident proton energy, source size, cell array size, buffer medium thickness layer, concentration and distribution of boron in the cell array. To quantitatively assess the effectiveness of PBFT, of the total energy deposition by alpha particle for different cases were determined. The number of alpha particle hits in cell cytoplasm and nucleus for normal and 100 ppm boron were determined. The obtained results and the developed tools would be useful for future development of PBFT to objectively determine the effectiveness of this treatment modality.
Original languageEnglish
Article number18098
JournalScientific Reports
Volume12
Online published27 Oct 2022
DOIs
Publication statusPublished - 2022

Publisher's Copyright Statement

  • This full text is made available under CC-BY 4.0. https://creativecommons.org/licenses/by/4.0/

Fingerprint

Dive into the research topics of 'On the effectiveness of proton boron fusion therapy (PBFT) at cellular level'. Together they form a unique fingerprint.

Cite this